Hb of < 100 g/L broadly constitutes moderate-to-severe anemia, and while supportive therapies are typically considered at this threshold, the introduction of RBC transfusions may be reserved for more severely anemic individuals [3, 13–17]. This evidence concerns the gene GSTM1 and anemia.